Default company panoramic image

Telephus Medical LLC

We are developing TPH 101, a novel monoclonal antibody to prevent MRSA biofilm infections in patients with artificial hip or knee implants.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location San Diego, CA, USA
  • Currency USD
  • Employees 7
  • Website

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.